Effects of somatostatin analog on splanchnic hemodynamics and plasma glucagon level in portal hypertensive rats

Table 2 Effects of octreotide on splanchnic blood flow (mL·g·min)

	Normal Cont	IHPH Cont	IHPH Thera	PHPH Cont	PHPH Thera
Stomach	0.59 ± 0.1	0.76 ± 0.2a	0.59 ± 0.1c	0.71 ± 0.1a	0.53 ± 0.1c
Intestine and mesentery	1.36 ± 0.1	1.65 ± 0.1a	1.11 ± 0.1ac	1.83 ± 0.2a	1.21 ± 0.1ac
Pancreas	0.84 ± 0.1	0.97 ± 0.1a	0.62 ± 0.1c	1.27 ± 0.2a	1.01 ± 0.2c
Spleen	0.98 ± 0.4	0.78 ± 0.2	0.46 ± 0.2ac	0.96 ± 0.2	0.72 ± 0.2c
Liver	0.58 ± 0.1	0.38 ± 0.1a	0.28 ± 0.1ac	0.99 ± 0.1ae	0.62 ± 0.1c

^aP < 0.05 vs unmodeled/untreated normal controls;

^cP < 0.05 vs control group;

^eP < 0.05 vs the IHPH control group.